News on BioMarin Pharmaceutical from BioPortfolio.com http://www.BioPortfolio.com Consolidated BioMarin Pharmaceutical news from BioPortfolio.com Wed, 10 Feb 2010 11:22:21 GMT en BioMarin to Acquire LEAD Therapeuticshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033090&HITNO=0&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033090&THISHREF=http://c.moreover.com/click/here.pl%3fz2535002573%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033090&HITNO=0&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033090&THISHREF=http://c.moreover.com/click/here.pl%3fz2535002573%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: Roth Capital Upgrades BioMarin Pharmaceutical (BMRN) to Buyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034633&HITNO=1&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034633&THISHREF=http://c.moreover.com/click/here.pl%3fz2535897750%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034633&HITNO=1&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034633&THISHREF=http://c.moreover.com/click/here.pl%3fz2535897750%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Cell Therapeutics, AstraZeneca lead drug stockshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037960&HITNO=2&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037960&THISHREF=http://c.moreover.com/click/here.pl%3fz2537397049%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037960&HITNO=2&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037960&THISHREF=http://c.moreover.com/click/here.pl%3fz2537397049%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarketWatch: Biotech Stocks: Drug stocks gain; Cell Therapeutics reboundshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036012&HITNO=3&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036012&THISHREF=http://c.moreover.com/click/here.pl%3fz2536463997%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036012&HITNO=3&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036012&THISHREF=http://c.moreover.com/click/here.pl%3fz2536463997%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarketWatch: Drug stocks gain; Cell Therapeutics reboundshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035768&HITNO=4&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035768&THISHREF=http://c.moreover.com/click/here.pl%3fz2536363185%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035768&HITNO=4&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035768&THISHREF=http://c.moreover.com/click/here.pl%3fz2536363185%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarketWatch: Biotechnology Stocks Top Losers (NASDAQ: CTIC, NVAX, BMRN)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034815&HITNO=5&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034815&THISHREF=http://c.moreover.com/click/here.pl%3fz2535986781%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034815&HITNO=5&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034815&THISHREF=http://c.moreover.com/click/here.pl%3fz2535986781%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Aker BioMarine (NO) - Aker BioMarine refinancing planhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032854&HITNO=6&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032854&THISHREF=http://c.moreover.com/click/here.pl%3fz2534835865%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032854&HITNO=6&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032854&THISHREF=http://c.moreover.com/click/here.pl%3fz2534835865%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: DnB NOR Markets gives 'sell' after Aker BioMarine unveils refinancing planhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038223&HITNO=7&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038223&THISHREF=http://c.moreover.com/click/here.pl%3fz2537535096%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038223&HITNO=7&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038223&THISHREF=http://c.moreover.com/click/here.pl%3fz2537535096%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comADP News: BioMarin Pharmaceutical to acquire Lead Therapeuticshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030817&HITNO=8&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030817&THISHREF=http://c.moreover.com/click/here.pl%3fz2533832702%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030817&HITNO=8&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030817&THISHREF=http://c.moreover.com/click/here.pl%3fz2533832702%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDrug Discovery News: BioMarin Pharmaceutical shares fall, Brean Murray analyst issues downgradehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030124&HITNO=9&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030124&THISHREF=http://c.moreover.com/click/here.pl%3fz2533453874%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030124&HITNO=9&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030124&THISHREF=http://c.moreover.com/click/here.pl%3fz2533453874%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDCExaminer.com: BioMarin to Acquire LEAD Therapeuticshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028640&HITNO=10&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028640&THISHREF=http://c.moreover.com/click/here.pl%3fz2532795636%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028640&HITNO=10&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028640&THISHREF=http://c.moreover.com/click/here.pl%3fz2532795636%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Technology: BioMarin Pharmaceutical (BMRN) NewsBite - BMRN Downgraded By Brean Murrayhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030998&HITNO=11&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030998&THISHREF=http://c.moreover.com/click/here.pl%3fz2533929475%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030998&HITNO=11&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030998&THISHREF=http://c.moreover.com/click/here.pl%3fz2533929475%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarket Intelligence Center: BioMarin Pharmaceutical (BMRN) Downgraded By Brean Murrayhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030690&HITNO=12&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030690&THISHREF=http://c.moreover.com/click/here.pl%3fz2533765349%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030690&HITNO=12&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030690&THISHREF=http://c.moreover.com/click/here.pl%3fz2533765349%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarket Intelligence Center: Biotech Stocks: BioMarin, Cell Therapeutics lead drug stocks southhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029958&HITNO=13&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029958&THISHREF=http://c.moreover.com/click/here.pl%3fz2533355748%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029958&HITNO=13&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029958&THISHREF=http://c.moreover.com/click/here.pl%3fz2533355748%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarketWatch: China Biotech Week in Review: New Investments in Life Sciencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030219&HITNO=14&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030219&THISHREF=http://c.moreover.com/click/here.pl%3fz2533503609%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030219&HITNO=14&MSIZE=333&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioMarin%20Pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030219&THISHREF=http://c.moreover.com/click/here.pl%3fz2533503609%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSeeking Alpha: